Article
Effect of cytochrome P450 2C19 polymorphism on adverse cardiovascular events after drug-eluting stent implantation in a large Hakka population with acute coronary syndrome receiving clopidogrel in southern China.
European journal of clinical pharmacology - 1 Apr 2018
Zhong Zhixiong, Hou Jingyuan, Zhang Qifeng, Li Bin, Li Cunren, Liu Zhidong, Yang Min, Zhong Wei, He Xuebo, Wu Hesen, Zhong Miaocai, Zhao Pingsen
Abstract excerpt
BACKGROUND AND OBJECTIVES: The objective of this study is to evaluate the effects of cytochrome P450 2C19 (CYP2C19) polymorphism on adverse cardiovascular events (MACE) in Hakka patients with acute coronary syndrome (ACS) receiving clopidogrel who had undergone coronary drug-eluting stent placement after percutaneous coronary intervention (PCI) in southern China. METHODS: Genotyping of CYP2C19 and MACE of 934 ACS...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.